Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review

OBJECTIVE: This meta-analysis aimed to investigate the efficacy and safety of poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors in BRCA-mutated advanced breast cancer patients comprehensively. METHODS: We conducted a systematic literature research through PubMed, the Cochrane Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ximu, Wang, Xin, Zhang, Jie, Zhao, Zhixia, Feng, Xin, Liu, Lihong, Ma, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399371/
https://www.ncbi.nlm.nih.gov/pubmed/34455227
http://dx.doi.org/10.1016/j.breast.2021.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399371/
https://www.ncbi.nlm.nih.gov/pubmed/34455227
http://dx.doi.org/10.1016/j.breast.2021.08.009

Ejemplares similares